Palisade Bio (PALI) Capital Expenditures Growth (1y) (2011 - 2019)
Powered by 
Analysis
Palisade Bio (PALI) Capital Expenditures Growth (1y) (2011 - 2019) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -22.99% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 9.68% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 1,133.33% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | -37.81% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 142.64% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 22,433.30% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -73.62% |
| 10 | Palisade Bio | 440.73 Mn | 315.53 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2019 | -578.13% |
| Dec 31, 2018 | -660.29% |
| Mar 31, 2018 | 2,415.72% |
| Jun 30, 2017 | -88.60% |
| Mar 31, 2017 | -98.91% |
| Jun 30, 2016 | 4.41% |
| Mar 31, 2016 | -9.06% |
| Dec 31, 2015 | 34.54% |
| Sep 30, 2015 | 18.88% |
| Jun 30, 2015 | 135.17% |
| Mar 31, 2015 | -85.55% |
| Dec 31, 2014 | 456.07% |
| Sep 30, 2014 | -76.15% |
| Jun 30, 2014 | 810.17% |
| Mar 31, 2014 | 6,608.15% |
| Dec 31, 2013 | -28.76% |
| Sep 30, 2013 | 19,047.72% |
| Jun 30, 2013 | -87.38% |
| Dec 31, 2012 | -3.25% |
| Sep 30, 2012 | -88.45% |